Satoshi Takeuchi
Overview
Explore the profile of Satoshi Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
268
Citations
2597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takeuchi S, Zeze N, Imayama S, Nakahara T
J Dermatol
. 2025 Mar;
PMID: 40040571
No abstract available.
2.
Takenaka J, Watanabe S, Abe T, Takeuchi S, Hirata K, Kimura R, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40005979
: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that produce catecholamines. Unresectable or metastatic PPGLs are treated with [I]metaiodobenzylguanidine (MIBG), but MIBG avidity is often heterogeneous. Identifying predictive factors...
3.
4.
Noguchi T, Ariga S, Moku R, Kikuchi J, Amano T, Maeda T, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400437.
PMID: 39823560
Purpose: Precision medicine plays an important role in the treatment of patients with advanced melanoma. Despite its high incidence in White patients, advanced melanoma is rare in Asian countries, hampering...
5.
Takeuchi S, Ishikura Y, Takahara M, Kano R, Nakahara T
J Dermatol
. 2024 Oct;
52(3):e240-e241.
PMID: 39392074
No abstract available.
6.
Suzuki Y, Watanabe K, Kanno-Nozaki K, Horikoshi S, Ichinose M, Hirata Y, et al.
J Psychiatr Res
. 2024 Aug;
178:228-235.
PMID: 39163661
Background: Cognitive dysfunction is a core feature of schizophrenia. Although treatment-resistant schizophrenia (TRS) exhibits wide-ranging neuropsychological deficits, factors defining cognitive prognosis in TRS are unclear. We aimed to clarify the...
7.
Zhang H, Tsuchikawa T, Takeuchi S, Deng H, Tanaka K, Matsui A, et al.
World J Surg Oncol
. 2024 Aug;
22(1):209.
PMID: 39097743
Introduction: Survival comparisons among patients with liver metastases from pancreatic and rectal neuroendocrine tumors (NETs) were limited, and the efficacy of observation rules in patients undergoing hepatectomy for neuroendocrine liver...
8.
Zhang H, Tsuchikawa T, Takeuchi S, Hirata K, Tanaka K, Matsui A, et al.
Endocr J
. 2024 Jul;
71(9):873-880.
PMID: 39069495
As novel biomarkers for gastroenteropancreatic neuroendocrine tumors (GEPNET) are in demand, we aimed to validate the clinical value of the NETest in Japanese patients. Between 2021 and 2023, blood and...
9.
Imafuku S, Takeuchi S, Urabe K, Arakawa M, Sasaki R, Oka D, et al.
J Dermatol
. 2024 Jul;
51(10):1279-1289.
PMID: 39046277
Amenamevir is an oral once-daily antiherpesvirus drug that can be administered without dose adjustment in patients with impaired renal function. There are currently no clinical data on immunocompromised patients with...
10.
Kawabata-Iwakawa R, Iwasa N, Satoh K, Colinge J, Shimada M, Takeuchi S, et al.
Int J Clin Oncol
. 2024 May;
29(9):1334-1346.
PMID: 38767719
Background: Platinum/taxane (TC) chemotherapy with debulking surgery stays the mainstay of the treatment in ovarian cancer patients with peritoneal metastasis, and recently its novel modality, intraperitoneal carboplatin with dose-dense paclitaxel...